TECTONIC THERAPEUTIC, INC. Finance Lease, Liability, Noncurrent
TECTONIC THERAPEUTIC, INC. (TECX) had Finance Lease, Liability, Noncurrent of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Finance Lease, Liability, Noncurrent $0.00.
- 2026-03-31: Finance Lease, Liability, Noncurrent $17.00K.
- 2025-12-31: Finance Lease, Liability, Noncurrent $43.00K.
- 2025-09-30: Finance Lease, Liability, Noncurrent $100.00K.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $43.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $186.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $283.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $387.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $513.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $637.00K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $876.00K 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |